 | • レポートコード：MRC2301H017 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、259ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の市場調査によると、2021年の7,604.54百万ドルであった世界の医薬品添加剤市場規模は、2022年には8,096.22百万ドルへ達し、2027年までに年平均6.64%成長して11,185.58百万ドルへ拡大すると予想されています。本調査資料では、医薬品添加剤の世界市場を調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（）分析、製剤別（経口製剤、非経口製剤、局所製剤）分析、機能別（接合剤、コーティング剤、着色剤、崩壊剤、その他）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、当書ではAir Liquide S.A.、Archer Daniels Midland Company、Ashland Global Holdings Inc.、Associated British Foods PLC、BASF SE、Budenheim、Captisol、Colorcon Inc.、Croda International、Daicelなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の医薬品添加剤市場規模：種類別 - 無機医薬品添加剤の市場規模 - 有機医薬品添加剤の市場規模 ・世界の医薬品添加剤市場規模：製剤別 - 経口製剤における市場規模 - 非経口製剤における市場規模 - 局所製剤における市場規模 ・世界の医薬品添加剤市場規模：機能別 - 接合剤における市場規模 - コーティング剤における市場規模 - 着色剤における市場規模 - 崩壊剤における市場規模 - その他機能における市場規模 ・世界の医薬品添加剤市場規模：地域別 - 南北アメリカの医薬品添加剤市場規模 アメリカの医薬品添加剤市場規模 カナダの医薬品添加剤市場規模 ブラジルの医薬品添加剤市場規模 ... - アジア太平洋の医薬品添加剤市場規模 日本の医薬品添加剤市場規模 中国の医薬品添加剤市場規模 インドの医薬品添加剤市場規模 韓国の医薬品添加剤市場規模 台湾の医薬品添加剤市場規模 ... - ヨーロッパ/中東/アフリカの医薬品添加剤市場規模 イギリスの医薬品添加剤市場規模 ドイツの医薬品添加剤市場規模 フランスの医薬品添加剤市場規模 ロシアの医薬品添加剤市場規模 ... - その他地域の医薬品添加剤市場規模 ・競争状況 ・企業情報 |
The Global Pharmaceutical Excipient Market size was estimated at USD 7,604.54 million in 2021 and expected to reach USD 8,096.22 million in 2022, and is projected to grow at a CAGR 6.64% to reach USD 11,185.58 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Excipient to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Inorganic and Organic. The Inorganic is further studied across Calcium Carbonate, Calcium Phosphate, Calcium Sulfate, Halites, and Metal Oxides. The Organic is further studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins. The Carbohydrates is further studied across Cellulose, Starch, and Sugars. The Oleochemicals is further studied across Fatty Alcohols, Glycerin, and Mineral Stearates. The Petrochemicals is further studied across Acrylic Polymers, Glycols, Mineral Hydrocarbons, and Povidones.
Based on Formulation, the market was studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations is further studied across Capsules, Liquid Formulations, and Tablets. The Capsules is further studied across Hard Gelatin Capsules and Soft Gelatin Capsules.
Based on Function, the market was studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Excipient market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Excipient Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Excipient Market, including Air Liquide S.A., Archer Daniels Midland Company, Ashland Global Holdings Inc., Associated British Foods PLC, BASF SE, Budenheim, Captisol, Colorcon Inc., Croda International, Daicel, DMV-Fonterra Excipients GmbH & Co. KG, Dupont De Nemours, Inc., Evonik Industries AG, Fuji Chemical, GalenIQ, Gattefossé, Innophos Holdings Inc., JRS Pharma GmbH & Co. KG, Kerry Group PLC, Lubrizol Corporation, Lubrizol Life Science Health, Roquette Frères, and WACKER Chemie AG.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Excipient Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Excipient Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Excipient Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Excipient Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Excipient Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Excipient Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Excipient Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth of the pharmaceuticals market supported by functional excipients
5.1.1.2. Surge in the generics market & rising adoption of orphan drugs
5.1.2. Restraints
5.1.2.1. Increasing regulatory stringency
5.1.3. Opportunities
5.1.3.1. Shifting focus of pharmaceutical manufacturing to developing countries
5.1.3.2. Multifunctional excipient
5.1.4. Challenges
5.1.4.1. Changing trade policies between countries
5.2. Cumulative Impact of COVID-19
6. Pharmaceutical Excipient Market, by Type
6.1. Introduction
6.2. Inorganic
6.3.1. Calcium Carbonate
6.3.2. Calcium Phosphate
6.3.3. Calcium Sulfate
6.3.4. Halites
6.3.5. Metal Oxides
6.3. Organic
6.4.1. Carbohydrates
6.4.2.1. Cellulose
6.4.2.2. Starch
6.4.2.3. Sugars
6.4.2. Oleochemicals
6.4.3.1. Fatty Alcohols
6.4.3.2. Glycerin
6.4.3.3. Mineral Stearates
6.4.3. Petrochemicals
6.4.4.1. Acrylic Polymers
6.4.4.2. Glycols
6.4.4.3. Mineral Hydrocarbons
6.4.4.4. Povidones
6.4.4. Proteins
7. Pharmaceutical Excipient Market, by Formulation
7.1. Introduction
7.2. Oral Formulations
7.3.1. Capsules
7.3.2.1. Hard Gelatin Capsules
7.3.2.2. Soft Gelatin Capsules
7.3.2. Liquid Formulations
7.3.3. Tablets
7.3. Parenteral Formulations
7.4. Topical Formulations
8. Pharmaceutical Excipient Market, by Function
8.1. Introduction
8.2. Binders
8.3. Coating Agents
8.4. Colorants
8.5. Disintegrants
8.6. Emulsifying Agents
8.7. Fillers & Diluents
8.8. Flavoring Agents & Sweeteners
8.9. Lubricants & Glidants
8.10. Preservatives
8.11. Suspending & Viscosity Agents
9. Americas Pharmaceutical Excipient Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pharmaceutical Excipient Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pharmaceutical Excipient Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Air Liquide S.A.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Archer Daniels Midland Company
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Ashland Global Holdings Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Associated British Foods PLC
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. BASF SE
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Budenheim
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Captisol
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Colorcon Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Croda International
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Daicel
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. DMV-Fonterra Excipients GmbH & Co. KG
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Dupont De Nemours, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Evonik Industries AG
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Fuji Chemical
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. GalenIQ
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Gattefossé
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Innophos Holdings Inc.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. JRS Pharma GmbH & Co. KG
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Kerry Group PLC
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Lubrizol Corporation
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Lubrizol Life Science Health
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Roquette Frères
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. WACKER Chemie AG
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing